A study presented at the annual meeting of the American Society of Clinical Oncology and published online by the NEJMindicates Exemestane, which is now used to prevent recurrences of breast cancer, can also reduce the risk of it occurring in the first place.

To read the full text you can go to: http://www.nejm.org/doi/full/10.1056/NEJMoa1103507